Craft

Taiho Pharmaceutical

Revenue

¥139.4 B

FY, 2022

Taiho Pharmaceutical Summary

Company Summary

Overview
Taiho Pharmaceutical (大鵬薬品) is a company that researches, manufactures, and markets medicines, food supplements, and medical devices. It offers prescription drugs, consumer healthcare products, and designated quasi-drugs. The company also develops oral anticancer agents for stomach cancer, colorectal cancer, pancreatic cancer, etc.
Type
Subsidiary
Status
Active
Founded
1963
HQ
Tokyo, JP | view all locations
Website
https://www.taiho.co.jp
Cybersecurity rating
Sectors

Key People

  • Masayuki Kobayashi

    Masayuki Kobayashi, Representative Director and President

    • Utsugi Teruhiro, Executive Director, Board Member, Research & Development

    • Makoto Miura

      Makoto Miura, Director, Global Marketing

    • Fabio Benedetti, Global Chief Medical Officer

    Operating MetricsView all

    Trademarks

    520

    Jun, 2023

    Trademark Applications

    65

    Jun, 2023

    Business Areas

    3

    Jun, 2023

    LocationsView all

    11 locations detected

    • Tokyo, Tokyo HQ

      Japan

      1-27 Kandanishiki-cho

    • Menlo Park, CA

      United States

      2420 Sand Hill Rd #203

    • Princeton, NJ

      United States

      101 Carnegie Center

    • Oakville, ON

      Canada

      2010 Winston Park Drive, Suite 503

    • Beijing

      China

      9A3, Hanwei Plaza, 7th, Guanghua Rd

    • Nagoya, Aichi

      Japan

      Nagoya Center Building Annex, 2-2-22

    and 5 others

    Taiho Pharmaceutical Financials

    Summary Financials

    Revenue (FY, 2022)
    ¥139.4B
    Net income (FY, 2022)
    ¥5.1B
    EBIT (FY, 2022)
    ¥3.1B

    Footer menu